100% renewable electricity by 2030; 83.2% achieved in 2025 AbbVie has a centralized Renewable Energy fund to increase active sourcing of renewable electricity. Progress reached 83.2% by year-end 2025 (up from 29.5% in 2021 baseline), with target of 100% by 2030. AbbVie procures renewable electricity through Energy Attribute Certificates including RECs, IRECs and European Guarantees of Origin. On-site photovoltaic solar installations operate at six sites: Ballytivnan (Ireland), Barceloneta (Puerto Rico), Campoverde (Italy), Ludwigshafen (Germany), Heredia (Costa Rica), and Liège (Belgium). Campoverde solar plant expansion delivered ~900 tCO2e annual savings.
▾ expand
New environmental targets effective 2026 AbbVie established new environmental targets effective 2026: establish water management plans at all high-risk sites by 2030; reduce net water intake normalized to revenue by 10% by 2035 from 2025 base year; reduce hazardous and non-hazardous waste normalized to revenue by 10% by 2035 from 2025 base year.
▾ expand
ISO 45001 occupational health & safety certification Ten internal manufacturing locations (two of which are shared R&D facilities) and two commercial affiliate offices are currently ISO 45001 certified.
▾ expand
Multiple strategic acquisitions and licensing deals In 2025 AbbVie completed acquisitions and licensing of Capstan Therapeutics, Nimble Therapeutics, Gilgamesh Pharmaceuticals, Ichnos Glenmark Innovation, Gubra and ADARx Pharmaceuticals, bolstering pipeline with more than $5 billion in business development.
▾ expand
2025 water reduction target achieved AbbVie surpassed its 2015 baseline-based 20% water withdrawal reduction target, achieving 20.1% reduction including noncontact cooling water.
▾ expand
Enhanced Scope 3 calculation tools During 2025 AbbVie developed robust calculator tools to measure emissions across applicable Scope 3 categories and created visual overviews of the data-collection process. Long-term decarbonization plan aligned with 1.5°C pre-industrial baseline is being developed.
▾ expand
Major increase in renewable electricity procurement Renewable electricity purchases increased from 60% globally in 2024 to over 80% in 2025, driving significant Scope 2 market-based emissions reductions.
▾ expand
Biodiversity Roadmap and third-party site risk screening Conducted geographic biodiversity risk screening of third-party manufacturing locations using WWF Biodiversity Risk Filter; identified five priority sites for further evaluation of biodiversity-related dependencies and impacts.
▾ expand
Sustainable Packaging targets By 2035 all packaging shall be widely recoverable and recyclable; by 2035 all packaging not classified as contact sensitive to include 30% recycled content; by 2030 transportation packaging shall not exceed 40% empty space.
▾ expand
No carbon offset purchases for near-term targets AbbVie has not purchased, and does not currently anticipate purchasing, carbon offset credits to meet its near-term science-based targets. Decarbonization relies on direct operational reductions, fleet electrification, energy efficiency, renewable electricity procurement, and supplier engagement rather than removals or offsets.
▾ expand
see 6 more events →